AKT1 and Insulin resistance: Overall, these molecular and biochemical findings highlight the ability of the ethanolic extract of GP to modulate the PI3K/Akt signalling pathway and associated downstream targets, underpinning its role as a natural candidate for the treatment of insulin resistance and hyperglycaemia (Feng et al., 2024).